OMCL icon

Omnicell

31.26 USD
-0.14
0.45%
At close Apr 30, 4:00 PM EDT
After hours
30.98
-0.28
0.90%
1 day
-0.45%
5 days
1.17%
1 month
-10.58%
3 months
-31.01%
6 months
-41.07%
Year to date
-29.47%
1 year
16.60%
5 years
-57.12%
10 years
-12.02%
 

About: Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.

Employees: 3,670

0
Funds holding %
of 7,425 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

1,039% more call options, than puts

Call options by funds: $38.5M | Put options by funds: $3.38M

70% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 30

44% more repeat investments, than reductions

Existing positions increased: 105 | Existing positions reduced: 73

7% more funds holding

Funds holding: 258 [Q3] → 276 (+18) [Q4]

4% more capital invested

Capital invested by funds: $1.99B [Q3] → $2.06B (+$72.9M) [Q4]

0.68% more ownership

Funds ownership: 99.13% [Q3] → 99.81% (+0.68%) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q3] → 1 (+0) [Q4]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$36
15%
upside
Avg. target
$45
45%
upside
High target
$62
98%
upside

3 analyst ratings

positive
33%
neutral
67%
negative
0%
Wells Fargo
Stan Berenshteyn
30% 1-year accuracy
3 / 10 met price target
22%upside
$38
Equal-Weight
Maintained
17 Apr 2025
JP Morgan
Anne Samuel
50% 1-year accuracy
17 / 34 met price target
15%upside
$36
Neutral
Maintained
20 Mar 2025
Benchmark
Bill Sutherland
44% 1-year accuracy
19 / 43 met price target
98%upside
$62
Buy
Maintained
4 Feb 2025

Financial journalist opinion

Based on 3 articles about OMCL published over the past 30 days

Positive
Zacks Investment Research
2 days ago
Why Omnicell (OMCL) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Omnicell (OMCL) is a Top Value Stock for the Long-Term
Neutral
Zacks Investment Research
1 week ago
Is it Apt to Retain Omnicell Stock in Your Portfolio Now?
OMCL stays on investors' radar due to the strong performance of the SaaS and Expert Services portfolio.
Is it Apt to Retain Omnicell Stock in Your Portfolio Now?
Positive
Zacks Investment Research
2 weeks ago
Here's Why Omnicell (OMCL) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Omnicell (OMCL) is a Strong Value Stock
Positive
Zacks Investment Research
1 month ago
Why Omnicell (OMCL) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Omnicell (OMCL) is a Top Value Stock for the Long-Term
Neutral
Business Wire
1 month ago
Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer.
Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer
Neutral
Business Wire
1 month ago
Omnicell Announces Chief Financial Officer Transition
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces Chief Financial Officer Transition.
Omnicell Announces Chief Financial Officer Transition
Positive
Zacks Investment Research
1 month ago
Omnicell Gains 41.6% in a Year: What's Driving the Stock?
OMCL's shares rise on the back of its XT Amplify program gaining market acceptance with its offerings. However, the unfavorable macroeconomic scenario is concerning.
Omnicell Gains 41.6% in a Year: What's Driving the Stock?
Positive
Zacks Investment Research
2 months ago
Is it Apt to Retain Omnicell Stock in Your Portfolio Now?
OMCL stays on investors' radar due to its impressive long-term growth initiative.
Is it Apt to Retain Omnicell Stock in Your Portfolio Now?
Positive
Zacks Investment Research
2 months ago
Omnicell (OMCL) Upgraded to Buy: What Does It Mean for the Stock?
Omnicell (OMCL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Omnicell (OMCL) Upgraded to Buy: What Does It Mean for the Stock?
Positive
Seeking Alpha
2 months ago
Omnicell Q4 Earnings: Ignore The Short-Term Noise
Omnicell's Q4 2024 earnings showed strong service revenue growth, despite soft overall revenue guidance, highlighting the service business as the key value driver. My updated DCF analysis yields a price target of $64.05, representing a 54% upside, and I raise my rating from buy to strong buy. The service business has grown from 6% to 22% of revenue since 2020, outpacing industry growth and improving margins, indicating long-term value.
Omnicell Q4 Earnings: Ignore The Short-Term Noise
Charts implemented using Lightweight Charts™